Albumin Dialysis for Liver Failure: A Systematic Review

Advances in Chronic Kidney Disease

Volumn 22, Issue 5, 2015, Pages 382-390

  Tsipotis, Evangelos ^a,b   Shuja, Asim ^a,b   Jaber, Bertrand L ^a,b  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Albumin dialysis; First pass albumin dialysis; Liver failure; MARS; Prometheus

Indexed keywords

AMMONIA; BILE ACID; BILIRUBIN; ALBUMINOID;

ALBUMIN DIALYSIS; AMMONIA BLOOD LEVEL; BILE ACID BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING DISORDER; CLINICAL EFFECTIVENESS; FRACTIONATED PLASMA SEPARATION ADSORPTION AND HEMODIALYSIS; HEMODIALYSIS; HEPATIC ENCEPHALOPATHY; HUMAN; INTERMETHOD COMPARISON; LIFE SUPPORT EQUIPMENT; LIVER FAILURE; LIVER SUPPORT; META ANALYSIS; MORTALITY; PATIENT SAFETY; PLASMAPHERESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE PASS ALBUMIN DIALYSIS; SURVIVAL RATE; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME; ADVERSE EFFECTS; DIALYSIS; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; LIVER TRANSPLANTATION; MALE; PROCEDURES; RISK ASSESSMENT;

ALBUMINS; DIALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; WAITING LISTS;

EID: 84952025435     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2015.05.004     Document Type: Review

References (29)

1. Hassanein T.I., Schade R.R., Hepburn I.S. Acute-on-chronic liver failure: extracorporeal liver assist devices. Curr Opin Crit Care 2011, 17(2):195-203.
2. Stange J. Extracorporeal liver support. Organogenesis 2011, 7(1):64-73.
3. Struecker B., Raschzok N., Sauer I.M. Liver support strategies: cutting-edge technologies. Nat Rev Gastroenterol Hepatol 2014, 11(3):166-176.
4. Tolwani A., While K. Extracorporeal liver support and the kidney. Critical Care Nephrology 2009, 1061-1067. Saunders Elsevier, Philadelphia, PA. 2nd ed.
5. Gambro Molecular adsorbent recirculating system 2014, Accessed November 28, 2014. http://www.gambro.com/en/global/Therapies/Molecular-Adsorbent-Recirculating-Systems1/?tab=documentTab#tabList.
6. Vaid A., Chweich H., Balk E.M., Jaber B.L. Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis. ASAIO J 2012, 58(1):51-59.
7. Saliba F., Camus C., Durand F., et al. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med 2013, 159(8):522-531.
8. Banares R., Nevens F., Larsen F.S., et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology 2013, 57(3):1153-1162.
9. Sauer I.M., Goetz M., Steffen I., et al. In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). Hepatology 2004, 39(5):1408-1414.
10. Ringe H., Varnholt V., Zimmering M., et al. Continuous veno-venous single-pass albumin hemodiafiltration in children with acute liver failure. Pediatr Crit Care Med 2011, 12(3):257-264.
11. Rifai K., Ernst T., Kretschmer U., et al. Prometheus-a new extracorporeal system for the treatment of liver failure. J Hepatol 2003, 39(6):984-990.
12. Kribben A., Gerken G., Haag S., et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology 2012, 142(4):782-789.e3.
13. Hozo S.P., Djulbegovic B., Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005, 5:13.
14. 2 index?. Psychol Methods 2006, 11(2):193-206.
15. Mitzner S.R., Stange J., Klammt S., et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transplant 2000, 6(3):277-286.
16. Heemann U., Treichel U., Loock J., et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002, 36(4 pt 1):949-958.
17. El Banayosy A., Kizner L., Schueler V., Bergmeier S., Cobaugh D., Koerfer R. First use of the Molecular Adsorbent Recirculating System technique on patients with hypoxic liver failure after cardiogenic shock. ASAIO J 2004, 50(4):332-337.
18. Sen S., Davies N.A., Mookerjee R.P., et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transplant 2004, 10(9):1109-1119.
19. Hassanein T.I., Tofteng F., Brown R.S., et al. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007, 46(6):1853-1862.
20. Laleman W., Wilmer A., Evenepoel P., et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure. Crit Care 2006, 10(4):R108.
21. Dethloff T., Tofteng F., Frederiksen H.J., Hojskov M., Hansen B.A., Larsen F.S. Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study. World J Gastroenterol 2008, 14(13):2065-2071.
22. Wiesner R., Edwards E., Freeman R., et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003, 124(1):91-96.
23. Weiss J.S., Gautam A., Lauff J.J., et al. The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia. N Engl J Med 1983, 309(3):147-150.
24. Morita M., Amuro Y, Hada T, et al. Protein-bound and unbound bile acids in serum of patients with liver cirrhosis. Hepatol Res 1998, 10(3):217-224.
25. Butterworth R.F. Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure. J Clin Exp Hepatol 2015, 5(Suppl 1):S96-S103.
26. Beckman J.S. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996, 9(5):836-844.
27. Montoliu C., Cauli O., Urios A., et al. 3-nitro-tyrosine as a peripheral biomarker of minimal hepatic encephalopathy in patients with liver cirrhosis. Am J Gastroenterol 2011, 106(9):1629-1637.
28. Frost M.T., Halliwell B., Moore K.P. Analysis of free and protein-bound nitrotyrosine in human plasma by a gas chromatography/mass spectrometry method that avoids nitration artifacts. Biochem J 2000, 345(pt 3):453-458.
29. Zheng Z., Li X., Li Z., Ma X. Artificial and bioartificial liver support systems for acute and acute-on-chronic hepatic failure: a meta-analysis and meta-regression. Exp Ther Med 2013, 6(4):929-936.